Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Dihexa's HGF-mimetic properties offered a neuroprotective approach that could theoretically work alongside or independently of amyloid biology
For the regulatory details, see our Tesamorelin FDA approval status guide or compare the Tesamorelin research peptide page
Tesamorelin is FDA-approved for reducing visceral adipose tissue (VAT) 4 in HIV-associated lipodystrophy, achieving ~1518% VAT reduction in clinical trials, with added benefits for liver and lipid health
For example, rising U.S
US$ 24.59
US$ 20.68
US$ 26.06
US$ 28.01
US$ 29.64
US$ 22.47
